← Back
$KYMR All transactions

Kymera Therapeutics, Inc.

▼ SELL 10b5-1 Plan

$ Value

$1.5M

Shares

30,000

Price

$49

Filed

Jun 3

Insider

Name

Mainolfi Nello

Title

Chief Executive Officer

CIK

0001821189

Roles

Director Officer

Transaction Details

Transaction Date

2025-06-03

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

660,482

Footnotes

These transactions were effected pursuant to a Rule 10b5-1 trading plan dated September 6, 2024 adopted by the reporting person. | This number includes 523 shares acquired under the Registrant's employee stock purchase plan on June 2, 2025. | The shares underlying this stock option are fully vested and exercisable.

Filing Info

Accession No.

0000950170-25-081199

Form Type

4

Issuer CIK

0001815442

Mainolfi Nello's History

Date Ticker Type Value
2025-09-16 KYMR M $62K
2025-09-16 KYMR $1.5M
2025-09-16 KYMR M $0
2025-06-03 KYMR M $62K
2025-06-03 KYMR $1.5M
2025-06-03 KYMR M $0

Other Insiders at KYMR (90d)

Insider Bought Sold Last
Chadwick Jeremy G
Chief Operating Officer
$11.5M 2026-04-15
Booth Bruce $855K 2026-04-15
Ridloff Elena $1.0M 2026-04-01
Goodman Noah
Chief Business Officer
$1.0M 2026-04-14